Clinical Research Directory
Browse clinical research sites, groups, and studies.
Administration of Fingolimod in Greek Patients With Multiple Sclerosis.
Sponsor: Elpen Pharmaceutical Co. Inc.
Summary
The goal of this observational study is to evaluate the efficacy of fingolimod through the estimation of the annualized relapse rate (ARR) over a period of 2 years. Participants who are already taking fingolimod as part of their regular medical care for MS will answer questions about their medical history for the past 1 year and for their status for the next 2 years.
Official title: Administration of Fingolimod in Greek Patients With Multiple Sclerosis for the Evaluation of the Efficacy and Safety, Based on the Standard Clinical Practice.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
140
Start Date
2025-06-01
Completion Date
2027-12-31
Last Updated
2025-05-02
Healthy Volunteers
No